Beta-lactam-induced severe neutropaenia: a descriptive study

Non-chemotherapy drug-induced neutropenia - an update

(2017) Emmanuel Andrès et al.   Expert Opinion On Drug Safety

Neutropenia induced by high-dose intravenous benzylpenicillin in treating neurosyphilis: Does it really matter?

(2017) Rui-Rui Peng et al.   PLoS Neglected Tropical Diseases

High incidence of neutropenia in patients with prolonged ceftaroline exposure

(2016) Kari J. Furtek et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Nonchemotherapy drug-induced agranulocytosis in children detected by a prospective pharmacovigilance program

(2016) Nicolás Medrano-Casique et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Pharmacokinetics and pharmacogenomics of β-lactam-induced neutropenia

(2016) Andrea Hahn et al.   PHARMACOGENOMICS

Characteristics of Antithyroid Drug–Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years

(2016) Jun Yang et al.   THYROID

Higher Risk of Neutropenia Associated With Piperacillin-Tazobactam Compared With Ticarcillin-Clavulanate in Children

(2014) P. Lemieux et al.   CLINICAL INFECTIOUS DISEASES

Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis

(2014) Alexander Johnston et al.   Expert Opinion on Drug Metabolism & Toxicology

Drug-induced agranulocytosis in the Berlin case–control surveillance study

(2013) Matthias Huber et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Drug-induced neutropenia due to direct effects on CFU-C - Ten years of culture experience

(2010) Alexandra E. Irvine et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Cephalosporin-Induced Leukopenia Following Rechallenge with Cefoxitin

(2008) Craig B Whitman et al.   ANNALS OF PHARMACOTHERAPY

Incidence and risk factors for agranulocytosis in Latin American countries—the Latin Study

(2008) Nelson Hamerschlak et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Use of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosis

(2008) L. Ibáñez et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY